Abstract
Background
Polygenic risk score (PRS) prediction is widely used to assess the risk of diagnosis and progression of many diseases. Routinely, the weights of individual SNPs are estimated by the linear regression model that assumes independent and linear contribution of each SNP to the phenotype. However, for complex multifactorial diseases such as Alzheimer's disease, diabetes, cardiovascular disease, cancer, and others, association between individual SNPs and disease could be non-linear due to epistatic interactions. The aim of the presented study is to explore the power of non-linear machine learning algorithms and deep learning models to predict the risk of multifactorial diseases with epistasis.
Results
First, we tested ensemble tree methods and deep learning neural networks against LASSO linear regression model on simulated data with different types and strength of epistasis. The results showed that with the increase of strength of epistasis effect, non-linear models significantly outperform linear. Then the higher performance of non-linear models over linear was confirmed on real genetic data for multifactorial phenotypes such as obesity, type 1 diabetes, and psoriasis. From non-linear models, gradient boosting appeared to be the best model in obesity and psoriasis while deep learning methods significantly outperform linear approaches in type 1 diabetes.
Conclusions
Overall, our study underscores the efficacy of non-linear models and deep learning approaches in more accurately accounting for the effects of epistasis in simulations with specific configurations and in the context of certain diseases.